1 - 3 of 3
1
Journal article icon

Journal article

Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen.

  • Davies, C
  • 2004-10-05
2
Journal article icon

Journal article

Single-agent purine analogues for the treatment of chronic lymphocytic leukaemia: a systematic review and meta-analysis.

  • Steurer, M, Pall, G, Richards, S, et al.
  • 2006-08-05
3
Journal article icon

Journal article

Fludarabine increases complete response but not survival compared with conventional alkylator-based regimens for previously untreated chronic lymphocytic leukaemia.

  • Richards, S
  • 2005-06-05
FILTER RESULTS

TO TOP